Dyve Biosciences, in collaboration with Moffitt Cancer Center, today reported significant study results for a first-of-its-kind investigational therapy applied to the skin and des ...

A study demonstrates that levels of the CTHRC1 protein in tumor-associated fibroblasts can predict immunotherapy outcomes in ...

Current research investigates novel biomarkers that can predict therapeutic outcomes. Finding ways to determine therapeutic ...

Determining the presence of a protein in non-tumor cells within the cancer microenvironment could be one of the keys to ...

South Korea's Penetrium Bioscience unveiled a novel approach to cancer treatment that targets the environments surrounding ...

Despite major advances in targeted therapies, immunotherapies, and combination regimens, therapy resistance remains a central barrier to durable cancer ...

Researchers are launching a new project to crack the mystery of aggressive breast cancer, where predicting disease ...

The data to be presented show that Geminii's bioelectronic therapy slowed tumor growth, extended survival, and enhanced the activity of chemoradiation in multiple preclinical NSCLC models without ...

Pancreatic cancer research tackles treatment resistance with targeted drug delivery, immune-boosting combinations, and ...